Urovo Technology Co., Ltd.

SZSE:300531 Rapport sur les actions

Capitalisation boursière : CN¥4.8b

Urovo Technology Résultats passés

Passé contrôle des critères 0/6

Urovo Technology's earnings have been declining at an average annual rate of -34%, while the Electronic industry saw earnings growing at 3.9% annually. Revenues have been growing at an average rate of 6.4% per year.

Informations clés

-34.0%

Taux de croissance des bénéfices

-35.5%

Taux de croissance du BPA

Electronic Croissance de l'industrie10.9%
Taux de croissance des recettes6.4%
Rendement des fonds propres-15.4%
Marge nette-18.1%
Dernière mise à jour des bénéfices30 Sep 2024

Mises à jour récentes des performances passées

Recent updates

Urovo Technology Co., Ltd.'s (SZSE:300531) Shares Climb 59% But Its Business Is Yet to Catch Up

Oct 08
Urovo Technology Co., Ltd.'s (SZSE:300531) Shares Climb 59% But Its Business Is Yet to Catch Up

Is Urovo Technology (SZSE:300531) A Risky Investment?

Sep 27
Is Urovo Technology (SZSE:300531) A Risky Investment?

Optimistic Investors Push Urovo Technology Co., Ltd. (SZSE:300531) Shares Up 45% But Growth Is Lacking

Aug 23
Optimistic Investors Push Urovo Technology Co., Ltd. (SZSE:300531) Shares Up 45% But Growth Is Lacking

Urovo Technology (SZSE:300531) Will Want To Turn Around Its Return Trends

Jul 25
Urovo Technology (SZSE:300531) Will Want To Turn Around Its Return Trends

Urovo Technology's (SZSE:300531) Dividend Will Be CN¥0.05

May 26
Urovo Technology's (SZSE:300531) Dividend Will Be CN¥0.05

Calculating The Intrinsic Value Of Urovo Technology Co., Ltd. (SZSE:300531)

Mar 27
Calculating The Intrinsic Value Of Urovo Technology Co., Ltd. (SZSE:300531)

Urovo Technology Co., Ltd.'s (SZSE:300531) 27% Price Boost Is Out Of Tune With Earnings

Mar 06
Urovo Technology Co., Ltd.'s (SZSE:300531) 27% Price Boost Is Out Of Tune With Earnings

Capital Allocation Trends At Urovo Technology (SZSE:300531) Aren't Ideal

Feb 28
Capital Allocation Trends At Urovo Technology (SZSE:300531) Aren't Ideal

Ventilation des recettes et des dépenses

Comment Urovo Technology gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

SZSE:300531 Recettes, dépenses et bénéfices (CNY Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Sep 241,282-232179114
30 Jun 241,285-213174113
31 Mar 241,287-180180108
31 Dec 231,268-167181105
30 Sep 231,307106153109
30 Jun 231,364135161105
31 Mar 231,41314316490
01 Jan 231,41115616194
30 Sep 221,40215018279
30 Jun 221,45014117479
31 Mar 221,41113916590
31 Dec 211,41715416285
30 Sep 211,39413316594
30 Jun 211,30212616792
31 Mar 211,29113815589
31 Dec 201,15911914981
30 Sep 209859911885
30 Jun 209575212683
31 Mar 208032812479
31 Dec 199515112274
30 Sep 191,0299412478
30 Jun 191,09414110375
31 Mar 191,14713911971
01 Jan 1995211710872
30 Sep 1885610710566
30 Jun 18598737184
31 Mar 18488605469
01 Jan 18443496256
30 Sep 17401716336
30 Jun 1736970910
31 Mar 1733768830
31 Dec 1633368790
30 Sep 1630464710
30 Jun 1629262660
31 Mar 1628663630
31 Dec 1527359640
31 Dec 1421647590
31 Dec 1320146580

Des revenus de qualité: 300531 is currently unprofitable.

Augmentation de la marge bénéficiaire: 300531 is currently unprofitable.


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: 300531 is unprofitable, and losses have increased over the past 5 years at a rate of 34% per year.

Accélération de la croissance: Unable to compare 300531's earnings growth over the past year to its 5-year average as it is currently unprofitable

Bénéfices par rapport au secteur d'activité: 300531 is unprofitable, making it difficult to compare its past year earnings growth to the Electronic industry (1.2%).


Rendement des fonds propres

ROE élevé: 300531 has a negative Return on Equity (-15.42%), as it is currently unprofitable.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé